Trends in Life Expectancy of HIV-positive Adults on Antiretroviral Therapy Across the Globe: Comparisons with General Population

Overview

Journal Curr Opin HIV AIDS

Specialty Infectious Diseases

Date 2016 Jun 3

PMID 27254748

Citations 182

Authors

Gilles Wandeler

Leigh F Johnson

Matthias Egger

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Improved virological and immunological outcomes and reduced toxicity of antiretroviral combination therapy (ART) raise the hope that life expectancy of HIV-positive persons on ART will approach that of the general population. We systematically review the literature and summarize published estimates of life expectancy of HIV-positive populations on ART. We compare their life expectancy with the life expectancy of the general or, in sub-Saharan Africa, HIV-negative populations, by time period and gender.

Recent Findings: Ten relevant studies were published from 2006 to 2015. Three studies were from Canada, two from European countries, three from sub-Saharan Africa and two were multicountry studies. Life expectancy increased over time in all studies and regions. Expressed as the percentage of life expectancy in the HIV-negative or general population, estimated life expectancy at age 20 years in HIV-positive people on ART ranged from 60.3% (95% CI 58.0-62.6%) in Rwanda (2008-2011) to 89.1% (95% CI 84.7-93.6%) in Canada (2008-2012). The percentage of life expectancy in the HIV-negative or general population achieved was higher in HIV-positive women than in HIV-positive men in all countries, except for Canada wherein the opposite was the case.

Summary: Life expectancy in HIV-positive people on ART has improved worldwide in recent years, but important gaps remain compared with the general and HIV-negative population, and between regions and genders.

Citing Articles

Altered KEGG pathways are associated with different immunologic responses to antiretroviral therapy in HIV-infected men who have sex with men.

Zhao H, Luo D, Feng A, Zhou X, Lin Y, Chen Y BMC Infect Dis. 2025; 25(1):343.

PMID: 40069637 PMC: 11900107. DOI: 10.1186/s12879-025-10756-2.

Dementia prevalence and risk factors in people with and without HIV in Malawi: A medical record review.

Lee H, Mlombe Y, Song Y, Yang H, Phiri T, Maseke J Alzheimers Dement. 2025; 21(3):e70009.

PMID: 40042467 PMC: 11881610. DOI: 10.1002/alz.70009.

Construction and validation of a nomogram to predict 1-year mortality risk in patients with HIV/AIDS undergoing maintenance hemodialysis.

Xian Z, Song X, Wang Y, Yang T, Mao N Ren Fail. 2025; 47(1):2461665.

PMID: 39962711 PMC: 11837922. DOI: 10.1080/0886022X.2025.2461665.

Concordance between homeostatic model assessment and triglyceride glucose index in assessing insulin resistance among HIV-infected patients.

Budak G, Vatan A, Guclu E, Karabay O Saudi Med J. 2025; 46(2):157-162.

PMID: 39933767 PMC: 11822928. DOI: 10.15537/smj.2025.46.2.20240769.

Non-Parametric Estimation for Semi-Competing Risks Data With Event Misascertainment.

Wu R, Zhang Y, Bakoyannis G Stat Med. 2025; 44(3-4):e10332.

PMID: 39853796 PMC: 11758483. DOI: 10.1002/sim.10332.

References

Guaraldi G, Cossarizza A, Franceschi C, Roverato A, Vaccher E, Tambussi G . Life expectancy in the immune recovery era: the evolving scenario of the HIV epidemic in northern Italy. J Acquir Immune Defic Syndr. 2014; 65(2):175-81. DOI: 10.1097/QAI.0000000000000018. View

May M, Gompels M, Delpech V, Porter K, Post F, Johnson M . Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ. 2011; 343:d6016. PMC: 3191202. DOI: 10.1136/bmj.d6016. View

Lundgren J, Babiker A, Gordin F, Emery S, Grund B, Sharma S . Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015; 373(9):795-807. PMC: 4569751. DOI: 10.1056/NEJMoa1506816. View

Weber R, Huber M, Battegay M, Stahelin C, Castro Batanjer E, Calmy A . Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study. HIV Med. 2014; 16(3):137-51. DOI: 10.1111/hiv.12184. View

Fox M, Rosen S . Retention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008-2013. J Acquir Immune Defic Syndr. 2015; 69(1):98-108. PMC: 4422218. DOI: 10.1097/QAI.0000000000000553. View

Koller M, Patel K, Chi B, Wools-Kaloustian K, Dicko F, Chokephaibulkit K . Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr. 2014; 68(1):62-72. PMC: 4351302. DOI: 10.1097/QAI.0000000000000380. View

Johnson L, Mossong J, Dorrington R, Schomaker M, Hoffmann C, Keiser O . Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med. 2013; 10(4):e1001418. PMC: 3621664. DOI: 10.1371/journal.pmed.1001418. View

Dias Lima V, Eyawo O, Ma H, Lourenco L, Chau W, Hogg R . The impact of scaling-up combination antiretroviral therapy on patterns of mortality among HIV-positive persons in British Columbia, Canada. J Int AIDS Soc. 2015; 18:20261. PMC: 4598331. DOI: 10.7448/IAS.18.1.20261. View

Johnson L, Dorrington R, Laubscher R, Hoffmann C, Wood R, Fox M . A comparison of death recording by health centres and civil registration in South Africans receiving antiretroviral treatment. J Int AIDS Soc. 2015; 18:20628. PMC: 4684576. DOI: 10.7448/IAS.18.1.20628. View

10.

Egger M, May M, Chene G, Phillips A, Ledergerber B, Dabis F . Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002; 360(9327):119-29. DOI: 10.1016/s0140-6736(02)09411-4. View

11.

. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008; 372(9635):293-9. PMC: 3130543. DOI: 10.1016/S0140-6736(08)61113-7. View

12.

Samji H, Cescon A, Hogg R, Modur S, Althoff K, Buchacz K . Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013; 8(12):e81355. PMC: 3867319. DOI: 10.1371/journal.pone.0081355. View

13.

Brinkhof M, Pujades-Rodriguez M, Egger M . Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One. 2009; 4(6):e5790. PMC: 2686174. DOI: 10.1371/journal.pone.0005790. View

14.

Egger M, Johnson L . Estimating trends in life expectancy in HIV-positive individuals. Lancet Glob Health. 2015; 3(3):e122-3. DOI: 10.1016/S2214-109X(14)70383-3. View

15.

Avila D, Althoff K, Mugglin C, Wools-Kaloustian K, Koller M, Dabis F . Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr. 2014; 65(1):e8-16. PMC: 3894575. DOI: 10.1097/QAI.0b013e3182a39979. View

16.

Mills E, Bakanda C, Birungi J, Chan K, Ford N, Cooper C . Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med. 2011; 155(4):209-16. DOI: 10.7326/0003-4819-155-4-201108160-00358. View

17.

Sabin C . Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?. BMC Med. 2013; 11:251. PMC: 4220799. DOI: 10.1186/1741-7015-11-251. View

18.

Geng E, Odeny T, Lyamuya R, Nakiwogga-Muwanga A, Diero L, Bwana M . Retention in Care and Patient-Reported Reasons for Undocumented Transfer or Stopping Care Among HIV-Infected Patients on Antiretroviral Therapy in Eastern Africa: Application of a Sampling-Based Approach. Clin Infect Dis. 2015; 62(7):935-944. PMC: 4787603. DOI: 10.1093/cid/civ1004. View

19.

Lepretre A, Ba I, Lacombe K, Maynart M, Toufik A, Ndiaye O . Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study. J Int AIDS Soc. 2015; 18:19888. PMC: 4442125. DOI: 10.7448/IAS.18.1.19888. View

20.

Patterson S, Cescon A, Samji H, Chan K, Zhang W, Raboud J . Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada. BMC Infect Dis. 2015; 15:274. PMC: 4504463. DOI: 10.1186/s12879-015-0969-x. View